儿童糖尿病面貌的改变
本综述旨在更新儿童1型和2型糖尿病的流行病学、临床表现、合并症与并发症,并总结当前及新兴治疗。儿童糖尿病发病率上升,肥胖增加使分型困难但分型仍对优化治疗、预判并发症和预测疾病风险重要。新兴治疗以血糖控制、限制体重增加、改善生活质量和减少合并症为最终目标。
要点
- 儿童糖尿病发病率上升,肥胖增加使1型与2型糖尿病分型日益困难。
- 分型对优化治疗、预判并发症和预测疾病风险仍很重要。
- 新兴治疗以血糖控制、限制体重增加、改善生活质量和减少合并症为目标。
核心结论
- 儿童糖尿病发病率上升,肥胖增加使1型与2型糖尿病分型困难但分型仍重要,新兴治疗以血糖控制、限制体重增加、改善生活质量和减少合并症为最终目标。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 儿童糖尿病发病率上升,肥胖在所有青少年中持续增加,使1型与2型糖尿病分型日益困难。
- 分型对优化治疗、预判并发症和预测疾病风险仍很重要。
- 新兴治疗正在出现,最终目标是实现血糖控制、限制体重增加、改善生活质量和减少合并症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The purpose of this review is to provide an update on the changing face of paediatric type 1 diabetes and type 2 diabetes. Paediatric diabetes is on the rise, with extensive research dedicated to understanding its pathophysiology, comorbidities and complications. As obesity continues to increase among all youth, differentiating between type 1 diabetes and type 2 diabetes has become increasingly difficult but remains important for optimising treatment, anticipating complications and predicting disease risk. Novel treatments are emerging, with the ultimate goal being to achieve glycaemic control, limit weight gain, improve quality of life and reduce comorbidities. In this review, we focus on updates regarding the epidemiology, clinical presentation, comorbidities and complications of paediatric type 1 diabetes and type 2 diabetes and conclude with current and emerging treatments.
引用
- Shah AS, Nadeau KJ. The changing face of paediatric diabetes. Diabetologia. 2020. PMID: 31897525. doi:10.1007/s00125-019-05075-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。